West Pharmaceutical Services, Inc.

WST · Healthcare

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) has been publicly traded since 1980, making it a 46-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Exton, United States and employs approximately 10,800 people. With a market capitalization of $17 billion, WST is a large established company.

Key Statistics

Current Price
$235.46
Market Cap
$16.96B
52-Week High
$322.34
52-Week Low
$187.43
Sector
Healthcare
Industry
Medical Instruments & Supplies

$1,000 Invested

1 Year
$1,056
+6%
3 Years
$753
+-25%
5 Years
$892
+-11%
10 Years
$3,772
+277%
Since IPO
$546,678
+54568%

Monthly Returns Heatmap

Annual Returns

Avg Return
+18.05%
Best Year
2006 (+107.69%)
Worst Year
2022 (-49.70%)
Positive Years
31/46
Year Return Start End
2026 -14.34% $274.89 $235.46
2025 -15.73% $326.20 $274.89
2024 -6.75% $349.82 $326.20
2023 +49.97% $233.27 $349.82
2022 -49.70% $463.74 $233.27
2021 +65.88% $279.57 $463.74
2020 +89.05% $147.88 $279.57
2019 +54.13% $95.95 $147.88
2018 -0.08% $96.02 $95.95
2017 +17.02% $82.06 $96.02
2016 +41.87% $57.84 $82.06
2015 +14.03% $50.72 $57.84
2014 +9.52% $46.31 $50.72
2013 +81.24% $25.55 $46.31
2012 +46.63% $17.43 $25.55
2011 -6.37% $18.61 $17.43
2010 +6.92% $17.41 $18.61
2009 +5.58% $16.49 $17.41
2008 -5.70% $17.48 $16.49
2007 -19.85% $21.81 $17.48
2006 +107.69% $10.50 $21.81
2005 +1.74% $10.32 $10.50
2004 +50.89% $6.84 $10.32
2003 +43.54% $4.77 $6.84
2002 -5.25% $5.03 $4.77
2001 +11.58% $4.51 $5.03
2000 -18.30% $5.52 $4.51
1999 -11.73% $6.25 $5.52
1998 +22.45% $5.11 $6.25
1997 +7.38% $4.75 $5.11
1996 +22.79% $3.87 $4.75
1995 -13.00% $4.45 $3.87
1994 +14.35% $3.89 $4.45
1993 +10.83% $3.51 $3.89
1992 +23.23% $2.85 $3.51
1991 +56.33% $1.82 $2.85
1990 -33.87% $2.76 $1.82
1989 +28.84% $2.14 $2.76
1988 -8.60% $2.34 $2.14
1987 +20.25% $1.95 $2.34
1986 +9.18% $1.78 $1.95
1985 +46.81% $1.21 $1.78
1984 -32.21% $1.79 $1.21
1983 +34.19% $1.34 $1.79
1982 +1.97% $1.31 $1.34
1981 +75.72% $0.75 $1.31

Valuation

WST currently trades at a trailing P/E ratio of 34.7, which is considered high relative to the broader market. The forward P/E of 26.6 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 5.3. The price-to-sales ratio is 5.5.

Dividends

West Pharmaceutical Services, Inc. pays a dividend to shareholders with a current yield of 0.37%. This translates to $0.88 per share annually. The payout ratio of 13% indicates sustainable dividend coverage.

Risk & Volatility

WST has a beta of 1.18, indicating it is slightly more volatile than the overall market. The stock's 52-week range is $187.43 to $322.34, and it currently trades in the lower half of its 52-week range.

Analyst Ratings

Based on 14 analyst opinions, WST has a consensus "strong_buy" rating. The average price target of $318.36 suggests 35.2% upside from current levels.

Frequently Asked Questions

What does West Pharmaceutical Services, Inc. do?

West Pharmaceutical Services, Inc. is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Exton, United States.

What sector is WST in?

WST operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.

When did WST go public?

West Pharmaceutical Services, Inc. went public in 1980, making it a 46-year-old public company as of 2026.

How much would $1,000 invested in WST 5 years ago be worth today?

A $1,000 investment in WST five years ago would be worth approximately $892 today, representing a -10.8% return.

Does WST pay dividends?

Yes, West Pharmaceutical Services, Inc. pays a dividend with a current yield of 0.37%, which is $0.88 per share annually.

What is WST's market cap?

West Pharmaceutical Services, Inc. has a market capitalization of $17 billion, classifying it as a large-cap company.

What is WST's P/E ratio?

WST has a trailing P/E ratio of 34.7 and a forward P/E of 26.6, which measures how much investors are paying per dollar of earnings.

Is WST a buy, hold, or sell?

Based on 14 opinions, WST has a consensus "strong_buy" rating. The average price target is $318.36.

Last updated: 3/14/2026